Intervencion Farmaceutica Intervencion Farmaceutica Plaquetarios En Diabeticos Tipo 2

Publisher:
Sociedad Espanola de Farmacia Comunitaria
Publication Type:
Journal Article
Citation:
Farmaceuticos Comunitarios, 2010, 2 (4), pp. 135 - 138
Issue Date:
2010-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2013003429OK.pdf138.11 kB
Adobe PDF
OBJECTIVES To measure the prevalence of type 2 diabetic patients using antiplatelet platelet therapy for cardiovascular prophylaxis and assess the impact of a pharmacist intervention on its use. METHODS Quasi-experimental study in a community pharmacy in Palmera (Valencia), Spain. The study was conducted from November 2007 to January 2008. RESULTS Participants twenty of the 58 type 2 diabetic patients selected, fifteen (51.7%) used at the beginning antiplatelet therapy. Only one patient (11.1%) received no antiplatelet for secondary prevention, primary prevention while using seven (35%). As for not using Ten met the criteria established in the clinical practice guidelines for initial use and underwent surgery. After the intervention, three patients started using antiplatelet. CONCLUSIONS In this small group of diabetics, the use of antiplatelet agents is not overextended after the intervention increased
Please use this identifier to cite or link to this item: